Distribution and favorable prognostic implication of genomic EGFR alterations in IDH-wildtype glioblastoma.
Higa N, Akahane T, Hamada T, Yonezawa H, Uchida H, Makino R, Watanabe S, Takajo T, Yokoyama S, Kirishima M, Matsuo K, Fujio S, Hanaya R, Tanimoto A, Yoshimoto K.
Higa N, et al. Among authors: makino r.
Cancer Med. 2023 Jan;12(1):49-60. doi: 10.1002/cam4.4939. Epub 2022 Jun 13.
Cancer Med. 2023.
PMID: 35695190
Free PMC article.